Influenza Like Illness ILI SARS-CoV-2 Panel Test sale cost 2000 AED
Bordetella Multiplex Bordetella Pertussis Legionella Pneumophila Klebsiella Pneumonia and Mycoplasma Pneumonia Detection and Differentiation RNA Detection Qualitative Test sale cost 2720 AED Bordetella Multiplex Bordetella Pertussis Legionella Pneumophila Klebsiella Pneumonia and Mycoplasma Pneumonia Detection and Differentiation RNA Detection Qualitative Test 3,200 د.إ 2,720 د.إ
Lyme Disease Borrelia Burgdorferi IgG and IgM Immunoblot Test sale cost 2570 AED Lyme Disease Borrelia Burgdorferi IgG and IgM Immunoblot Test 2,860 د.إ 2,570 د.إ
Sale!

Influenza Like Illness ILI SARS-CoV-2 Panel Test

2,000 د.إ

-33%

The Influenza Like Illness (ILI) SARS-CoV-2 Panel Test is a comprehensive diagnostic tool available at DNA Labs UAE, designed to accurately identify the presence of SARS-CoV-2—the virus responsible for COVID-19—as well as other pathogens that cause influenza-like symptoms. Priced at 2000 AED, this panel test is an essential resource in the clinical assessment of patients presenting with symptoms such as fever, cough, sore throat, and body aches, which are common to a variety of respiratory infections.

By simultaneously testing for multiple viruses, the ILI SARS-CoV-2 Panel Test enables healthcare providers to swiftly differentiate between SARS-CoV-2 and other respiratory viruses, facilitating timely and appropriate treatment decisions. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test employs the latest in molecular diagnostic technology to ensure high sensitivity and specificity, offering patients and healthcare professionals alike peace of mind through accurate and reliable results.

Given the overlapping symptoms of many respiratory infections, the ability to accurately distinguish between them, especially in the context of the ongoing COVID-19 pandemic, is invaluable. The ILI SARS-CoV-2 Panel Test represents a significant advancement in the management and containment of respiratory infectious diseases, contributing to improved patient outcomes and public health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test

At DNA Labs UAE, we offer the INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test to help diagnose respiratory illnesses during flu seasons. This diagnostic test is used to detect both influenza viruses and the SARS-CoV-2 virus (which causes COVID-19) in individuals who exhibit symptoms similar to influenza.

Test Components

  • Sars-CoV-2 (Covid-19) RT-PCR
  • H1N1 RT-PCR
  • H3N2 & Influenza B RT-PCR

Price

The cost of the INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test is 2000.0 AED.

Sample Condition

To perform the test, please submit Nasopharyngeal and Oropharyngeal Swabs inoculated in special viral transport medium (VTM) available from LPL. These samples should be shipped refrigerated in a special transport box available from LPL. Additionally, please ensure to fill the Swine Flu / H1N1 Clinical Information Form (Form 25) and Covid-19 Clinical Information Form (Form 44) or provide the SRF ID as mandated by GOI.

Report Delivery

The test reports are delivered daily by 11 am for samples submitted, with the exception of Sundays. The report is typically available within 2 days.

Method

The INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test is performed using Real Time RT-PCR method.

Test Type

This test is used to detect infections.

Doctor

The test can be ordered by a physician.

Test Department

The test is conducted in the Test Department of DNA Labs UAE.

Pre Test Information

It is mandatory to fill the Swine Flu / H1N1 Clinical Information Form (Form 25) and Covid-19 Clinical Information Form (Form 44) or provide the SRF ID as mandated by GOI before undergoing the test.

Test Details

The INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test is designed to simultaneously detect and differentiate between the influenza A virus, influenza B virus, and the SARS-CoV-2 virus using molecular techniques like PCR (Polymerase Chain Reaction) or RT-PCR (Reverse Transcription Polymerase Chain Reaction). By testing for both influenza viruses and SARS-CoV-2 at the same time, healthcare providers can quickly identify the cause of the illness and take appropriate actions such as initiating isolation or quarantine protocols, providing appropriate treatment, or recommending further testing. The test is typically performed using respiratory samples, such as nasal or throat swabs, which are collected from the patient. These samples are then processed in a laboratory, where the genetic material of the viruses is extracted and amplified for detection. It is important to note that this test is not a substitute for specific testing for COVID-19 alone. If someone is suspected to have COVID-19 but tests negative for influenza, further testing for SARS-CoV-2 may still be necessary. The INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test plays a crucial role in diagnosing respiratory illnesses during flu seasons, especially when there is a need to differentiate between influenza and COVID-19, as the symptoms of these illnesses can overlap.

Test Name INFLUENZA LIKE ILLNESS ILI SARS-CoV-2 PANEL Test
Components *Sars-CoV-2 (Covid-19) RT-PCR *H1N1 RT-PCR *H3N2 & Influenza B RT-PCR
Price 2000.0 AED
Sample Condition Submit Nasopharyngeal and Oropharyngeal Swabs inoculated in special viral transport medium (VTM) available from LPL. Ship refrigerated in a special transport box available from LPL. Duly filled Swine Flu \/ H1N1 Clinical Information Form (Form 25) and Covid-19 Clinical Information Form (Form 44) \/ SRF ID as mandated by GOI is mandatory.
Report Delivery Sample Daily by 11 am: Report 2 days (Except Sundays)
Method Real Time RT-PCR
Test type Infections
Doctor Physician
Test Department:
Pre Test Information Duly filled Swine Flu / H1N1 Clinical Information Form (Form 25) and Covid-19 Clinical Information Form (Form 44) / SRF ID as mandated by GOI is mandatory.
Test Details

The Influenza-Like Illness (ILI) SARS-CoV-2 Panel test is a diagnostic test used to detect both influenza viruses and the SARS-CoV-2 virus (which causes COVID-19) in individuals who exhibit symptoms similar to influenza.

This panel test is designed to simultaneously detect and differentiate between the influenza A virus, influenza B virus, and the SARS-CoV-2 virus using molecular techniques like PCR (Polymerase Chain Reaction) or RT-PCR (Reverse Transcription Polymerase Chain Reaction).

By testing for both influenza viruses and SARS-CoV-2 at the same time, healthcare providers can quickly identify the cause of the illness and take appropriate actions such as initiating isolation or quarantine protocols, providing appropriate treatment, or recommending further testing.

The ILI SARS-CoV-2 Panel test is typically performed using respiratory samples, such as nasal or throat swabs, which are collected from the patient. These samples are then processed in a laboratory, where the genetic material of the viruses is extracted and amplified for detection.

It is important to note that this test is not a substitute for specific testing for COVID-19 alone. If someone is suspected to have COVID-19 but tests negative for influenza, further testing for SARS-CoV-2 may still be necessary.

The ILI SARS-CoV-2 Panel test plays a crucial role in diagnosing respiratory illnesses during flu seasons, especially when there is a need to differentiate between influenza and COVID-19, as the symptoms of these illnesses can overlap.

SKU: TEST-4844 Category:

Related products